Drug information for DIMENHYDRINATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
50MG/ML
Prescription
AP
DIMENHYDRINATE
Dimenhydrinate
APP PHARMS
40519
INJECTABLE; INJECTION
50MG/ML
Prescription
AP (Reference Drug)
DIMENHYDRINATE
Dimenhydrinate
WATSON LABS
80615
INJECTABLE; INJECTION
50MG/ML
Discontinued
DIMENHYDRINATE
Dimenhydrinate
WATSON LABS
83531
INJECTABLE; INJECTION
50MG/ML
Discontinued
DIMENHYDRINATE
Dimenhydrinate
WYETH AYERST
84316
INJECTABLE; INJECTION
50MG/ML
Discontinued
DIMENHYDRINATE
Dimenhydrinate
BAXTER HLTHCARE
84767
LIQUID; ORAL
12.5MG/4ML
Discontinued
DIMENHYDRINATE
Dimenhydrinate
ALRA
80715
TABLET; ORAL
50MG
Discontinued
DIMENHYDRINATE
Dimenhydrinate
HEATHER
80841
TABLET; ORAL
50MG
Discontinued
DIMENHYDRINATE
Dimenhydrinate
WATSON LABS
85166
TABLET; ORAL
50MG
Discontinued
DIMENHYDRINATE
Dimenhydrinate
NEXGEN PHARMA INC
85985
Drug Adverse Effects information for DIMENHYDRINATE
Role code
Indications
Reaction
# Reports
SS
FOETAL EXPOSURE DURING PREGNANCY
GASTROSCHISIS
4
C
BLOOD PRESSURE SYSTOLIC
ASTHENIA
1
C
BLOOD PRESSURE SYSTOLIC
DECREASED APPETITE
1
C
BLOOD PRESSURE SYSTOLIC
NEOPLASM MALIGNANT
1
C
BLOOD PRESSURE SYSTOLIC
NEOPLASM PROGRESSION
1
C
BLOOD PRESSURE SYSTOLIC
RENAL FAILURE
1
C
BREAST CANCER METASTATIC
DEHYDRATION
2
C
BREAST CANCER METASTATIC
HYPERGLYCAEMIA
2
C
BREAST CANCER METASTATIC
HYPOKALAEMIA
2
C
BREAST CANCER METASTATIC
METABOLIC ALKALOSIS
2
C
BREAST CANCER METASTATIC
NEUTROPENIA
2
C
BREAST CANCER METASTATIC
PLATELET COUNT DECREASED
2
C
BREAST CANCER METASTATIC
SEPTIC SHOCK
2
C
CARCINOID TUMOUR
ASTHENIA
2
C
CARCINOID TUMOUR
DECREASED APPETITE
2
C
CARCINOID TUMOUR
NEOPLASM MALIGNANT
2
C
CARCINOID TUMOUR
NEOPLASM PROGRESSION
2
C
CARCINOID TUMOUR
RENAL FAILURE
2
C
CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC
ASTHENIA
1
C
CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC
DECREASED APPETITE
1
C
CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC
NEOPLASM MALIGNANT
1
C
CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC
NEOPLASM PROGRESSION
1
C
CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC
RENAL FAILURE
1
C
CROHN'S DISEASE
DECREASED APPETITE
1
C
CROHN'S DISEASE
DIARRHOEA
1
C
CROHN'S DISEASE
FEELING ABNORMAL
1
C
CROHN'S DISEASE
HERPES ZOSTER
1
C
CROHN'S DISEASE
HYPERSENSITIVITY
1
C
CROHN'S DISEASE
INTESTINAL MASS
1
C
CROHN'S DISEASE
LOCALISED INFECTION
1
C
CROHN'S DISEASE
SYNCOPE
1
C
CROHN'S DISEASE
VOMITING
1
C
CROHN'S DISEASE
WEIGHT DECREASED
1
C
DEPRESSION
CAESAREAN SECTION
1
C
DEPRESSION
MATERNAL EXPOSURE DURING PREGNANCY
1
C
MULTIPLE MYELOMA
DEATH
1
C
MULTIPLE MYELOMA
HEPATIC NEOPLASM MALIGNANT
2
C
MUSCLE RELAXANT THERAPY
DECREASED APPETITE
1
C
MUSCLE RELAXANT THERAPY
DIARRHOEA
1
C
MUSCLE RELAXANT THERAPY
FEELING ABNORMAL
1
C
MUSCLE RELAXANT THERAPY
HERPES ZOSTER
1
C
MUSCLE RELAXANT THERAPY
HYPERSENSITIVITY
1
C
MUSCLE RELAXANT THERAPY
INTESTINAL MASS
1
C
MUSCLE RELAXANT THERAPY
LOCALISED INFECTION
1
C
MUSCLE RELAXANT THERAPY
SYNCOPE
1
C
MUSCLE RELAXANT THERAPY
VOMITING
1
C
MUSCLE RELAXANT THERAPY
WEIGHT DECREASED
1
C
NAUSEA
ASTHENIA
1
C
NAUSEA
DECREASED APPETITE
1
C
NAUSEA
HEPATIC NEOPLASM MALIGNANT
1
C
NAUSEA
NEOPLASM MALIGNANT
1
C
NAUSEA
NEOPLASM PROGRESSION
1
C
NAUSEA
RENAL FAILURE
1
C
NEOPLASM MALIGNANT
ILEUS
2
C
NEOPLASM MALIGNANT
NAUSEA
2
C
NEOPLASM MALIGNANT
PNEUMONIA ASPIRATION
2
C
NEOPLASM MALIGNANT
VOMITING
2
C
NEURALGIA
APALLIC SYNDROME
2
C
NEURALGIA
ASTHENIA
2
C
NEURALGIA
BURNING FEET SYNDROME
2
C
NEURALGIA
CONDITION AGGRAVATED
2
C
NEURALGIA
DIZZINESS
2
C
NEURALGIA
HYPERHIDROSIS
2
C
NEURALGIA
NAUSEA
2
C
NEURALGIA
PAIN
2
C
NEURALGIA
RADICULOPATHY
2
C
NEURALGIA
RESTLESSNESS
2
C
NEURALGIA
VOMITING
2
C
PAIN
DECREASED APPETITE
2
C
PAIN
DIARRHOEA
2
C
PAIN
FEELING ABNORMAL
2
C
PAIN
HEPATIC NEOPLASM MALIGNANT
2
C
PAIN
HERPES ZOSTER
2
C
PAIN
HYPERSENSITIVITY
2
C
PAIN
INTESTINAL MASS
2
C
PAIN
LOCALISED INFECTION
2
C
PAIN
SYNCOPE
2
C
PAIN
VOMITING
2
C
PAIN
WEIGHT DECREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ATRIAL SEPTAL DEFECT
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DECREASED APPETITE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DIARRHOEA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG WITHDRAWAL SYNDROME NEONATAL
1
C
PRODUCT USED FOR UNKNOWN INDICATION
FEELING ABNORMAL
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMANGIOMA CONGENITAL
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HERPES ZOSTER
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
INTESTINAL MASS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
LARGE FOR DATES BABY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
LOCALISED INFECTION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL DRUGS AFFECTING FOETUS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
NEONATAL RESPIRATORY DISTRESS SYNDROME
1
C
PRODUCT USED FOR UNKNOWN INDICATION
PETECHIAE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY FAILURE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
SYNCOPE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
TRANSAMINASES INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
1
C
PRODUCT USED FOR UNKNOWN INDICATION
WEIGHT DECREASED
1
C
PROPHYLAXIS
HEPATIC NEOPLASM MALIGNANT
9
C
SLEEP DISORDER THERAPY
DECREASED APPETITE
1
C
SLEEP DISORDER THERAPY
DIARRHOEA
1
C
SLEEP DISORDER THERAPY
FEELING ABNORMAL
1
C
SLEEP DISORDER THERAPY
HERPES ZOSTER
1
C
SLEEP DISORDER THERAPY
HYPERSENSITIVITY
1
C
SLEEP DISORDER THERAPY
INTESTINAL MASS
1
C
SLEEP DISORDER THERAPY
LOCALISED INFECTION
1
C
SLEEP DISORDER THERAPY
SYNCOPE
1
C
SLEEP DISORDER THERAPY
VOMITING
1
C
SLEEP DISORDER THERAPY
WEIGHT DECREASED
1
C
SUPPLEMENTATION THERAPY
HEPATIC NEOPLASM MALIGNANT
3
C
UPPER RESPIRATORY TRACT INFECTION
HEPATIC NEOPLASM MALIGNANT
2
C
VITAMIN B12 DEFICIENCY
HEPATIC NEOPLASM MALIGNANT
1
I
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
6
I
PRODUCT USED FOR UNKNOWN INDICATION
VENTRICULAR TACHYCARDIA
6
Ads by Google